IRVINE, Calif.--(BUSINESS WIRE)--Sep. 7, 2016--
Masimo
(NASDAQ: MASI) today announced that its management is scheduled to
present at the Morgan Stanley Global Healthcare Conference at the Grand
Hyatt New York on Wednesday, September 14, 2016, at 1:00 p.m. Eastern
Time. A live audiocast of the presentation will be available on the
Masimo website at www.masimo.com.
A replay of the audiocast will be available following the live
presentation.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. Masimo SET® is estimated
to be used on more than 100 million patients in leading hospitals and
other healthcare settings around the world. In 2005, Masimo introduced
rainbow® Pulse CO-Oximetry technology, allowing noninvasive
and continuous monitoring of blood constituents that previously could
only be measured invasively, including total hemoglobin (SpHb®),
oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and more recently, Pleth Variability
Index (PVI®) and Oxygen Reserve Index (ORI™), in addition to
SpO2, pulse rate and perfusion index (PI). In 2014, Masimo introduced
Root®, an intuitive patient monitoring and connectivity
platform with the Masimo Open Connect™ (MOC-9™) interface. Masimo is
also taking an active leadership role in mHealth with products such as
the Radius-7™ wearable patient monitor and the MightySat™ fingertip
pulse oximeter. Additional information about Masimo and its products may
be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care... by Taking Noninvasive Monitoring to New
Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are
trademarks or registered trademarks of Masimo Corporation
View source version on businesswire.com: http://www.businesswire.com/news/home/20160907006763/en/
Source: Masimo
Masimo
Investor Contact: Eli Kammerman
949-297-7077
ekammerman@masimo.com
or
Media
Contact: Irene Paigah
858-859-7001
irenep@masimo.com